Stomatocytosis

Clinical trial pipeline · Data from ClinicalTrials.gov

See which Stomatocytosis trials you may qualify for

Total trials

Actively recruiting

Phase 3 trials

Completed

Trial phase breakdown

Trial status

Actively recruiting — 2 trials

RecruitingNot Applicable

NCT07206095

Integrative Diagnosis for SCD and Other RADs

INTEGRA aims at enabling personalized medicine for RHADs patients by the establishment of an integrative diagnostic approach based on deep phenotypic and geneti…

Spain200 participantsStarted 2020-11-13

Treatment: Analysis of genetic modifiers, Disease phenotyping

RecruitingNot Applicable

NCT04778657

National Exhaustive Cohort of Hereditary Stomatocytoses and Other Channelopathies Affecting the Red Blood Cell

Hereditary stomatocytosis is a heterogeneous group of rare constitutional diseases of dominant transmission in the vast majority of cases. The data concerning t…

France150 participantsStarted 2021-05-06

All recent trials (4 shown)

CompletedNot Applicable

NCT06831799

ERN-EuroBloodNet Registry on Patients With Rare Red Blood Cell Defects and COVID-19

Patients with red blood cell disorders (RBCDs), such as Sickle cell disease (SCD) and Thalassemia, are chronic, life-threatening conditions that can become mult…

Spain684 participantsStarted 2020-04-15

Treatment: Non applicable, is a patient registry

CompletedPhase 1/2

NCT04372498

Senicapoc and Dehydrated Stomatocytosis

Dehydrated stomatocytosis is a genetic disorder characterized by chronic hemolysis, variable anemia and erythrocyte dehydration. Causative mutations have been i…

United States5 participantsStarted 2021-04-15

Treatment: Senicapoc (synonyms: ICA-17043; 2,2-bis-(4-fluorophenyl)-2-phenylacetamide)